New patent for Astrazeneca Ab drug BYDUREON PEN

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fir…


Which pharmaceutical companies have the most SPCs in Spain?

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…


Biotechblog